Search results for "pediatric"

showing 10 items of 4528 documents

Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks

2019

Background For the prevention of attacks of hereditary angioedema (HAE), the efficacy and safety of subcutaneous human C1-esterase inhibitor (C1-INH[SC]; HAEGARDA, CSL Behring) was established in the 16-week Clinical Study for Optimal Management of Preventing Angioedema with Low-Volume Subcutaneous C1-Inhibitor Replacement Therapy (COMPACT). Objective To assess the long-term safety, occurrence of angioedema attacks, and use of rescue medication with C1-INH(SC). Methods Open-label, randomized, parallel-arm extension of COMPACT across 11 countries. Patients with frequent angioedema attacks, either study treatment-naive or who had completed COMPACT, were randomly assigned (1:1) to 40 IU/kg or …

AdultMalePediatricsmedicine.medical_specialtyAdolescentInjections SubcutaneousAttack rateC1-inhibitor03 medical and health sciencesYoung Adult0302 clinical medicinemedicineLong term outcomesImmunology and AllergyHumans030212 general & internal medicineddc:610Adverse effectChildAgedbiologyAngioedemabusiness.industryIncidence (epidemiology)Angioedemas HereditaryMiddle Agedmedicine.diseaseOptimal managementTreatment Outcome030228 respiratory systemHereditary angioedemabiology.proteinFemalemedicine.symptombusinessComplement C1 Inhibitor Protein
researchProduct

Population pharmacokinetic parameters of vancomycin in critically ill patients.

2006

Summary Background:  Intensive care unit patients are a highly heterogeneous population. Accurate dosing for this population requires characterization of the appropriate pharmacokinetic parameters. Objective:  To estimate population pharmacokinetic parameters of vancomycin (VAN) in adult critically ill patients and to establish the predictive performance of the resulting model. Patients and method:  Fifty critically ill patients with suspected or documented infection with VAN-sensitive micro-organisms were included. Thirty patients and 234 serum concentration–time sets obtained during clinical routine monitoring were used to estimate the pharmacokinetic parameters (group A). An open bicompa…

AdultMalePediatricsmedicine.medical_specialtyAdolescentMetabolic Clearance RatePopulationUrologyRenal functionlaw.inventionPharmacokineticslawVancomycinMedicineHumansPharmacology (medical)DosingeducationAntibacterial agentAgedRetrospective StudiesPharmacologyVolume of distributionAged 80 and overeducation.field_of_studybusiness.industryBayes TheoremMiddle AgedModels TheoreticalIntensive care unitNONMEMAnti-Bacterial AgentsIntensive Care UnitsCreatinineFemaleDrug MonitoringbusinessJournal of clinical pharmacy and therapeutics
researchProduct

Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States

2014

BackgroundAdulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to childhood ALL, survival for adults with ALL is poor. Recently, new protocols, including use of pediatric protocols in young adults, have improved survival in clinical trials. Here, we examine population level survival in Germany and the United States (US) to gain insight into the extent to which changes in clinical trials have translated into better survival on the population level.MethodsData were extracted from the Surveillance, Epidemiology, and End Results database in the US and 11 cancer registries in Germany. Patients age 15-69 diagnosed with ALL were included. Period analysis was used to estimate…

AdultMalePediatricsmedicine.medical_specialtyAdolescentNon-Clinical MedicineEpidemiologyScienceLymphoblastic LeukemiaBiostatisticsHematologic Cancers and Related DisordersGermanyLeukemiasEpidemiologyHumansMedicineStatistical MethodsYoung adultSurvival analysisAgedHealth Care PolicyMultidisciplinaryRelative survivalbusiness.industryStatisticsQRCancers and NeoplasmsCancerHematologyMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemiamedicine.diseaseSurvival AnalysisUnited StatesClinical trialOncologyUnited States ; age groups ; cancer treatment ; German people ; Germany ; cancer detection and diagnosis ; acute lymphoblastic leukemia ; leukemiasMedicineFemaleHealth StatisticsbusinessMathematicsResearch ArticleRare diseasePLoS ONE
researchProduct

Maternal body mass index in pregnancy and offspring physical and psychosocial functioning in older age: findings from the Helsinki Birth Cohort Study…

2016

Maternal obesity is associated with several adverse long-term health outcomes in the offspring. In this study, we examined the association between maternal body mass index (BMI) and offspring physical and psychosocial functioning in late adulthood.The study included 1759 men and women born during 1934-1944 and belonging to the Helsinki Birth Cohort Study. Data on maternal weight and height in late pregnancy and on offspring birth weight were retrieved from hospital birth records. Physical and psychosocial functioning was assessed using the Short Form 36 scale.Maternal BMI was positively associated with poorer physical and psychosocial functioning among men, but not among women. This associa…

AdultMalePediatricsmedicine.medical_specialtyAdolescentOffspringBirth weightHealth Status030209 endocrinology & metabolismOverweightBody Mass IndexCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineSex FactorsPregnancymedicineHumansphysical functioningMass index030212 general & internal medicineObesityFinland2. Zero hungerPregnancyoffspring healthbusiness.industrybirth weightGeneral Medicineta3142Middle AgedOverweightmedicine.diseasePregnancy Complicationsmaternal obesityAdult ChildrenFemalepsychosocial functioningmedicine.symptombusinessBody mass indexPsychosocialCohort studyDemographyAnnals of Medicine
researchProduct

Circulating 25-Hydroxyvitamin D3 in Pregnancy and Infant Neuropsychological Development

2012

OBJECTIVE:To investigate whether circulating 25-hydroxyvitamin D3 [25(OH)D3] concentration in pregnancy is associated with neuropsychological development in infants.METHODS:The Spanish population-based cohort study INfancia y Medio Ambiente Project recruited pregnant women during the first trimester of pregnancy between November 2003 and February 2008. Completed data on 1820 mother-infant pairs were used. Maternal plasma 25(OH)D3 concentration was measured by high-performance liquid chromatography in pregnancy (mean 13.5±2.1 weeks of gestation). Offspring mental and psychomotor scores were assessed by trained psychologists at age 14 months (range, 11–23) by using the Bayley Scales of Infant…

AdultMalePediatricsmedicine.medical_specialtyAdolescentOffspringNeuropsychological TestsBayley Scales of Infant Developmentvitamin D deficiencyCohort StudiesYoung AdultChild DevelopmentPregnancyInterquartile rangemedicineVitamin D and neurologyHumansProspective StudiesPrenatal Nutritional Physiological PhenomenaChromatography High Pressure LiquidCalcifediolPsychomotor learningPregnancybusiness.industryObstetricsInfantVitamin D Deficiencymedicine.diseasePregnancy ComplicationsPrenatal Exposure Delayed EffectsMultivariate AnalysisPediatrics Perinatology and Child HealthLinear ModelsGestationFemalebusinessBiomarkersPsychomotor PerformancePediatrics
researchProduct

Improvement in quality of life with omalizumab in patients with severe allergic asthma.

2006

Patients with severe persistent asthma experience daily symptoms and frequent serious exacerbations that contribute to a significant impairment of health-related quality of life (QoL).A pooled analysis was completed of six controlled clinical trials that evaluated the effect of add-on omalizumab on asthma-related QoL in patients with severe persistent allergic (IgE-mediated) asthma. Asthma-related QoL was assessed at baseline and treatment endpoint using the well-validated Juniper Asthma Quality of Life Questionnaire (AQLQ). Change from baseline in AQLQ total score was compared between treatments using analysis of covariance methods. The percentage of patients who achieved a clinically mean…

AdultMalePediatricsmedicine.medical_specialtyAdolescentOmalizumabOmalizumabAntibodies Monoclonal HumanizedSeverity of Illness IndexQuality of lifeSeverity of illnessHypersensitivityMedicineHumansIn patientAnti-Asthmatic AgentsChildAsthmaAgedRandomized Controlled Trials as Topicbusiness.industryAntibodies MonoclonalAllergic asthmaGeneral MedicineMiddle Agedmedicine.diseasehumanitiesAsthmaAntibodies Anti-IdiotypicClinical trialMeta-analysisQuality of LifeFemalebusinessmedicine.drugCurrent medical research and opinion
researchProduct

Patterns of intense physical activity among 15- to 30-year-old Finns

1996

Previous studies have reported increasing trends in physical activity in the Finnish population. These reports have not, however, included the perspective of cardiorespiratory stress in adolescent and young adults. We examined the present patterns of physical activity among Finnish adolescents and young adults in 1992. We specifically assessed whether the young people experience the volume of physical activity that is believed to stress the cardiorespiratory system appropriately in order to increase the level of fitness. The subjects in the present study were participants of a large multicenter study of atherosclerosis precursors in children and young adults. Physical activity was measured …

AdultMalePediatricsmedicine.medical_specialtyAdolescentPhysical fitnessPhysical activityPhysical Therapy Sports Therapy and RehabilitationPhysical exercise030204 cardiovascular system & hematologyCardiovascular Physiological Phenomena03 medical and health sciences0302 clinical medicineEpidemiologyHumansMedicineOrthopedics and Sports Medicine030212 general & internal medicineYoung adultFinlandbusiness.industryCardiorespiratory fitness16. Peace & justiceMulticenter studyAdolescent BehaviorPhysical FitnessRespiratory Physiological PhenomenaPopulation studyFemalebusinessDemographyScandinavian Journal of Medicine & Science in Sports
researchProduct

A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy

2014

Introduction Hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE type I) or dysfunction (C1-INH-HAE type II) is a rare disease characterized by recurrent episodes of edema with an estimated frequency of 1:50,000 in the global population without racial or gender differences. In this study we present the results of a nationwide survey of C1-INH-HAE patients referring to 17 Italian centers, the Italian network for C1-INH-HAE, ITACA. Methods Italian patients diagnosed with C1-INH-HAE from 1973 to 2013 were included in the study. Diagnosis of C1-INH-HAE was based on family and/or personal history of recurrent angioedema without urticaria and on antigenic and/or functional C1-INH def…

AdultMalePediatricsmedicine.medical_specialtyAdolescentPopulationNationwide surveyC1-inhibitorYoung AdultmedicineHumansGenetics(clinical)C1 inhibitor; C4; Hereditary angioedema; Adolescent; Adult; Angioedemas Hereditary; Female; Humans; Italy; Male; Middle Aged; Young Adult; Medicine (all); Genetics (clinical); Pharmacology (medical)Pharmacology (medical)Young adulteducationGenetics (clinical)C4Medicine(all)Hereditary angioedemaeducation.field_of_studyC1 inhibitorAngioedemabiologybusiness.industryResearchMedicine (all)Angioedemas HereditaryAngioedemasGeneral MedicineMiddle Agedbacterial infections and mycosesmedicine.diseaseSettore MED/16 - ReumatologiaHereditaryItalyHereditary angioedemabiology.proteinFemalemedicine.symptomDifferential diagnosisbusinessRare diseaseOrphanet Journal of Rare Diseases
researchProduct

European reference values for the quality of life questionnaire EORTC QLQ-C30: Results of a German investigation and a summarizing analysis of six Eu…

2014

The aims of this study are to present the results of a new general population normative study of the quality of life questionnaire EORTC QLQ-C30 and to give European reference values averaged across six studies.The empirical study was based on a representative sample of the German adult population (N = 2448). The subjects were asked to fill in several questionnaires, one of them being the EORTC QLQ-C30.EORTC QLQ-C30 mean scores of this sample indicated slightly better quality of life (QoL) than in previous European studies. QoL decreased with age, but there were only small gender differences. The mean scores were compared with the age and gender adjusted scores of five other European normat…

AdultMalePediatricsmedicine.medical_specialtyAdolescentPopulationSample (statistics)European studiesGermanYoung AdultQuality of lifeReference ValuesGermanyNeoplasmsSurveys and QuestionnairesmedicineHumansRadiology Nuclear Medicine and imagingeducationAgedAged 80 and overeducation.field_of_studybusiness.industryEortc qlq c30social sciencesHematologyGeneral MedicineMiddle Agedhumanitieslanguage.human_languageEuropeOncologyReference valuesQuality of LifelanguageNormativeFemalebusinessDemographyActa Oncologica
researchProduct

Immunity to tetanus in the 3-20 year age group in Italy

1997

In Italy, systematic mandatory tetanus immunization of children started in 1968. In 1989, immunity against tetanus was assessed in a random sample of 758 healthy subjects aged 3-20 y, from four Italian cities. There were 257 subjects 3-5 y old all residing in Southern Italy and 501 subjects 11-20 y old from both the South and North. The overall prevalence of non-immune subjects was 19.1%, without difference by sex. The rates of subjects lacking protective antibody titres was 25.3% in children 3-5 y old (all coming from South and the islands), 11.5% in those 11 y old, and 18.9% in the 18-20 y age-group, respectively. Subjects 11-20 y old residing in the South and the islands were more likely…

AdultMalePediatricsmedicine.medical_specialtyAdolescentTetanus immunizationTetanus.ImmunitymedicinePrevalenceTetanus ToxoidHumansChildHigh rateTetanusTetanusbusiness.industryPublic Health Environmental and Occupational HealthHealthy subjectsImmunityGeneral Medicinemedicine.diseaseAntibodies BacterialVaccinationItalyChild PreschoolFemaleProtective antibodyGeographical inequalitiesbusiness
researchProduct